Kedar Himanshu Dave

Title: Kedar Himanshu Dave: Innovator in Cell Therapy

Introduction

Kedar Himanshu Dave is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cell therapy, holding 2 patents that focus on improving therapeutic T cell compositions.

Latest Patents

His latest patents include "Phenotypic markers for cell therapy and related methods." This patent provides methods, compositions, and articles of manufacture for use in cell therapy involving the administration of therapeutic T cell compositions. The T cell compositions express recombinant receptors, such as chimeric antigen receptors (CARs) or other transgenic receptors like T cell receptors (TCRs). The features of this patent offer advantages such as consistent dosing, lower risk of toxicity, and increased response in subjects receiving the T cell compositions. Another notable patent is "Determining toxicity risk in CAR T-cell therapy." This patent outlines methods, compositions, and articles of manufacture for cell therapy, emphasizing the importance of the number of cells administered and their potency to reduce toxicity risks in subjects.

Career Highlights

Kedar currently works at Juno Therapeutics GmbH, where he continues to advance research in cell therapy. His work is pivotal in developing safer and more effective treatments for patients.

Collaborations

Kedar collaborates with notable colleagues, including Ryan P Larson and Christopher Glen Ramsborg, contributing to innovative research and development in the field.

Conclusion

Kedar Himanshu Dave is a key figure in the advancement of cell therapy, with his patents reflecting a commitment to improving patient outcomes. His work at Juno Therapeutics GmbH and collaborations with esteemed colleagues further enhance the impact of his innovations in the medical field.